Terms: = Gastric cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Staging
4 results:
1. Lymphangiogenesis in early and advanced gastric cancer: is there any difference?
Rudno-Rudzińska J; Donizy P; Frejlich E; Kotulski K; Dzięgiel P; Hałoń A; Kielan W
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():107-11. PubMed ID: 25521742
[TBL] [Abstract] [Full Text] [Related]
2. Does expression of receptor tyrosine kinases in gastric adenocarcinoma correlate with clinicopathological parameters?
Drescher D; Gockel I; Timm S; Berger MR; Herzer K; Schmidtmann I; Junginger T; Galle PR; Lang H; Moehler M; Schimanski CC
Hepatogastroenterology; 2010; 57(98):388-94. PubMed ID: 20583450
[TBL] [Abstract] [Full Text] [Related]
3. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?
Tsirlis TD; Papastratis G; Masselou K; Tsigris C; Papachristodoulou A; Kostakis A; Nikiteas NI
World J Gastroenterol; 2008 May; 14(17):2691-701. PubMed ID: 18461654
[TBL] [Abstract] [Full Text] [Related]
4. [Study on the correlation between the expressions of nm23H1 mRNA, VEGF-C mRNA and lymphatic metastases, survival rate with gastric cancer].
Ding GF; Li JC; Li CS; Xu YF; Sun Y; Chen XR
Fen Zi Xi Bao Sheng Wu Xue Bao; 2006 Feb; 39(1):46-54. PubMed ID: 16944571
[TBL] [Abstract] [Full Text] [Related]
